# Adjunct Treatment With Cariprazine for Adults With Attention-deficit/Hyperactivity Disorder

> **NCT04843423** · PHASE4 · UNKNOWN · sponsor: **Dr. Martin A. Katzman** · enrollment: 15 (estimated)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Cariprazine

## Key facts

- **NCT ID:** NCT04843423
- **Lead sponsor:** Dr. Martin A. Katzman
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-01
- **Primary completion:** 2022-12-30
- **Final completion:** 2023-04-14
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2021-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04843423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04843423, "Adjunct Treatment With Cariprazine for Adults With Attention-deficit/Hyperactivity Disorder". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04843423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*